Room Setting Preferences for Cancer Care

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: M.D. Anderson Cancer Center

Disqualifiers: Delirium, Dementia, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

406 Participants Needed

Trial Summary

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Preference of Room Setting and Waiting Time for cancer care?

Research shows that changes in the physical environment, like rearranging seating and playing soft music, can improve patient satisfaction with the care environment and wait times. Additionally, reducing wait times for treatment can enhance patient satisfaction and perceived quality of care. ^{1 2 3 4 5}

How does the room setting preference treatment for cancer care differ from other treatments?

This treatment focuses on the physical environment where cancer care is provided, such as private rooms or open areas, rather than a medical or drug-based approach. It aims to improve patient satisfaction and comfort by considering their preferences for the setting in which they receive care, which is a unique aspect compared to traditional treatments that focus solely on medical interventions. ^{3 5 6 7 8}

What is the purpose of this trial?

This trial studies the preference of room setting and waiting time in patients with cancer that has spread to nearby tissue or lymph nodes or other places in the body and their caregivers who are seen in the outpatient supportive/palliative care center. Room setting preferences of patients and caregivers may help to understand their opinion regarding direct rooming system in the outpatient supportive/palliative care center.

Research Team

MarieBerta Vidal

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

This trial is for patients with advanced cancer and their caregivers. Participants must be first-time visitors to the UTMDACC outpatient Supportive Care Center, able to give informed consent, and read/speak English or Spanish. Patients with delirium, dementia, or without a caregiver are excluded.

Inclusion Criteria

Patient must provide informed consent

Patient must be seen at University of Texas M. D. Anderson Cancer Center (UTMDACC) outpatient Supportive Care Center for consultation (first visit)

Patient must have a consenting caregiver at the time of the Supportive Care consultation visit

Exclusion Criteria

I do not have a caregiver at the time of my consultation visit.

I have been diagnosed with delirium or dementia.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Supportive Care (questionnaire)

Patients and their caregivers complete a questionnaire over 15 minutes either in person or over the phone within 3 days after their supportive care center visit

3 days

1 visit (in-person or phone)

Follow-up

Participants are monitored for their preferences and perceptions regarding room setting and waiting time

1 week

Treatment Details

Interventions

• Preference of Room Setting and Waiting Time

Trial Overview The study aims to understand preferences regarding room settings and waiting times at an outpatient supportive/palliative care center by using questionnaires administered to both patients with advanced cancer and their caregivers.

Participant Groups

Group I: Supportive Care (questionnaire) Experimental Treatment 1 Intervention

Patients and their caregivers complete a questionnaire over 15 minutes either in person or over the phone within 3 days after their supportive care center visit.

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials

3,107

Recruited

1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+

References

1. Canada pubmed.ncbi.nlm.nih.gov

Variability of waiting times for the 4 most prevalent cancer types in Ontario: a retrospective population-based analysis. [2023]

2. United States pubmed.ncbi.nlm.nih.gov

The Timeliness Initiative: Continuous Process Improvement for Prompt Initiation of Radiation Therapy Treatment. [2022]

3. United States pubmed.ncbi.nlm.nih.gov

Cancer patients' satisfaction with care in traditional and innovative ambulatory oncology clinics. [2015]

4. Canada pubmed.ncbi.nlm.nih.gov

Patient Satisfaction with Wait-Times for Breast Cancer Surgery in Newfoundland and Labrador. [2022]

5. United States pubmed.ncbi.nlm.nih.gov

Influences of Physical Layout and Space on Patient Safety and Communication in Ambulatory Oncology Practices: A Multisite, Mixed Method Investigation. [2022]

6. United States pubmed.ncbi.nlm.nih.gov

Private Rooms, Semi-Open Areas, or Open Areas for Chemotherapy Care: Perspectives of Cancer Patients, Families, and Nursing Staff. [2018]

7. Sweden pubmed.ncbi.nlm.nih.gov

Waiting times for cancer patients in Sweden: A nationwide population-based study. [2017]

8. England pubmed.ncbi.nlm.nih.gov

Cancer patients' preferences of care within hospitals: a systematic literature review. [2018]